Foot and Mouth Disease roadmap:
Vaccines
Roadmap for the development of candidate vaccines for FMD
Download FMD Vaccine Lead Summaries_Roadmap update8
Attenuated organisms
Dependencies
Next steps
- 3 Rationally attenuated candidates
- 3A Safety
- 3B Delivery route
- 3C Delivery platform
- 3D Efficacy in challenge model
The generation of rationally attenuated genetically modified FMD virus
Research Question
What are we trying to achieve and why? What is the problem we are trying to solve?
To generate organisms that are less virulent in terms of pathological changes that they cause and/or their ability to
modulate the host’s immune responses – rationally attenuated vaccine
Research Gaps and Challenges
What are the scientific and technological challenges (knowledge gaps needing to be addressed)?
- Ensure that the organisms are stable and can be produced in cell culture
- Ensure generation of a protective response
Solution Routes
What approaches could/should be taken to address the research question?
- Generation of infectious cDNA clones
- Generation and characterisation of a range of rationally attenuated organisms (using codon pair deoptimisation)
- Immune response to the attenuated organisms.
Dependencies
What else needs to be done before we can solve this need?
- Identity of virulence factors and their genes
- Identity of immunomodulators
State Of the Art
Existing knowledge including successes and failures
Projects
What activities are planned or underway?
A new blocking ELISA for detection of foot-and-mouth disease non-structural protein (NSP) antibodies in a broad host range.
Planned Completion date 12/09/2022
Source Countries:
Netherlands
Spatial model of foot and mouth disease outbreak in an endemic area of Thailand
Planned Completion date 01/10/2021
Source Countries:
Netherlands